Telesis Bio Inc EV/EBITDA
Qual é o EV/EBITDA de Telesis Bio Inc?
O EV/EBITDA de Telesis Bio Inc é N/A
Qual é a definição de EV/EBITDA?
EV/EBITDA é o valor da empresa dividido pelo lucro antes de juros, impostos, depreciação e amortização. É uma medida de quão cara é uma ação e é mais frequentemente válida para comparações entre empresas do que da relação entre preço e lucro. Ele mede o preço (na forma de valor da empresa) que um investidor paga em benefício do fluxo de caixa da empresa (na forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de empresas na Setor Health Care em NASDAQ em comparação com Telesis Bio Inc
O que Telesis Bio Inc faz?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Empresas com ev/ebitda semelhantes a Telesis Bio Inc
- Ximen Mining tem EV/EBITDA de N/A
- Rebel Capital 2.0 tem EV/EBITDA de N/A
- Hong Kong Johnson Hldg Co Ltd tem EV/EBITDA de N/A
- VOTI Detection tem EV/EBITDA de N/A
- Lift & Co tem EV/EBITDA de N/A
- Novatti tem EV/EBITDA de N/A
- Telesis Bio Inc tem EV/EBITDA de N/A
- In8 Bio tem EV/EBITDA de N/A
- Nitin Fire Protection Industries tem EV/EBITDA de N/A
- Renalytix AI plc tem EV/EBITDA de N/A
- Sunmirror Ag Sf 1 tem EV/EBITDA de N/A
- Sinotruk (Hong Kong) tem EV/EBITDA de N/A
- Cross River Ventures tem EV/EBITDA de N/A